Category Features

Interview With Vladimir Nika: Enforcing IP Rights In Albania 2010 – 2015

In 2010, institutions in Albania created a strategy to help enforce intellectual property rights within five years. Intellectual Property Watch recently conducted a written Q and A with Vladimir Nika, Albanian office director for the Eastern European law firm PETOŠEVIĆ, on the progress and prospects for the Albanian legislature’s implementation of the 2010 IPR enforcement strategy.

Trade And Development With A Dash Of IP: Conference To Set Course For UNCTAD

The quadrennial conference of the United Nations Conference on Trade and Development (UNCTAD) sets the course of the UN body work for the next four years. The mandate of the conference has evolved since its creation to become mainly a provider of research, policy analysis and technical assistance to developing countries. This time around, the conference will serve as a wide-ranging forum for trade and development issues, and intellectual property issues will haunt discussions in several areas.

WHO / EU “Bad Medicine” Plans: Flaws, Coordination Gaps

The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws, Daniele Dionisio writes.

Nigerian Courts Step Up Against Copyright Piracy: 18 Convicted

The last year has witnessed a series of convictions of copyright pirates by the Federal High Courts in Nigeria. Information provided by Afam Ezekude, the Director General of the Nigerian Copyright Commission, the government agency responsible for copyright matters, shows that the courts have convicted copyright infringers in 18 cases within the last 5 months (October 2011 to February 2012).

Intérêt de l’entreprise et choix stratégiques : les licences concédées par Gilead au Medicines Patent Pool

Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.